Related Experiment Videos
[Study on gene expression changes of arsenic sulfide treated NB4 cells]
Chunhong Gu1, Fangyuan Chen, Jieying Han
1Department of Hematology, Renji Hospital, Shanghai Second Medical University, Shanghai 200001, China.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|May 17, 2002
Summary
Arsenic sulfide treatment alters gene expression in NB4 cells, impacting apoptosis and cell cycle pathways. Key genes like ABC50, PNAS-2, and cyclin G(2) may drive arsenic-induced cell death.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Context:
- NB4 cells are a human promyelocytic leukemia cell line.
- Arsenic sulfide is a traditional Chinese medicine with potential anti-cancer properties.
- Understanding gene expression changes is crucial for evaluating therapeutic efficacy.
Purpose:
- To investigate the global gene expression profile of NB4 cells following arsenic sulfide treatment using cDNA microarray.
- To identify specific genes and pathways affected by arsenic sulfide exposure.
Summary:
- Gene expression analysis of NB4 cells before and after arsenic sulfide treatment revealed significant alterations.
- Thirty-four genes related to apoptosis and cell cycle were differentially expressed, with 28 upregulated and 6 downregulated.
- Genes such as ABC50, PNAS-2, and cyclin G(2) were identified as potentially involved in arsenic-induced apoptosis.
Impact:
- Provides insights into the molecular mechanisms of arsenic sulfide in leukemia treatment.
- Identifies potential therapeutic targets for NB4 cell apoptosis.
- Contributes to the understanding of gene regulation in response to anti-cancer agents.